Oncotarget is a free-access multidisciplinary that publishes online in weekly articles on scientific issues. It was first founded in 2010 at the hands of Impact Journals. This online journal has the latest in scientific research and the best researchers in the world at its disposal. Its original primary area of research was oncology, but the journal has proven to be so successful that other areas of scientific research are being explored. It is so popular that the Oncotarget team long ago decided to allow for extra printings whenever there is extra large demand. The journal is peer reviewed and is published by Impact Journals.
Its many articles are peer reviewed every week. It is currently helmed by editors-in-chief Mikhail Blagosklonny and Andrei Gudkov. The two are both extremely knowledgeable about medical topics. Blgosklonny attended First Pavlov State Medical University where he earned his M.D. and his Doctor of Philosophy degree. He is an internationally recognized expert on cancer and the aging process. He teaches his vast knowledge of these things at the Roswell Park Cancer Institute. Gudkov is a native of Moscow, where he led research in the Experimental Oncology from the Cancer Research Center before immigrating to the U.S. in 1990.
In 2001 he became the chairperson of the Department of Cell Stress Biology at Roswell Park Cance. He would hold this position until 2007. Since June 2003 Gudkov has been the Chief Scientific Officer of Equilar Atlas. Oncotarget is presently presenting its new Altmetric article platform, which tracks articles through digital and traditional media channels. The considerable resources and research of Oncotarget is available to medical professionals all over the world. But it does more than give access to its articles to all of these international medical professionals. They are also encouraged to contribute with their own research findings. Visit Oncotarget’s profile page at facebook.com
The team of Oncotarget makes absolutely sure that research expressed in their issues are fully accurate and of the highest quality. Its present areas of specialization include endocrinology, neuroscience immunology, microbiology cardiology, aging chromosome neuropathology, cell biology, and pharmacology. Oncotarget forsees adding new areas of research to this in the future.